Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Raymond James Financial, Inc. Common Stock (NY: RJF )

159.84 -0.55 (-0.34%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Raymond James Financial, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Can T-Mobile Shares Keep Heading Higher?
T-Mobile downgraded by Raymond James after 42% YTD stock rally. Strong Q3 results: earnings beat, raised guidance, and partnerships. Technical outlook: Bullish above $235; bearish entry near $228. 
Via Talk Markets
Topics Earnings
Exposures Financial
Shares of Raymond James Are Rising Today, While S&P Global and Globe Life Are Falling
Several companies in the financial sector reported earnings recently. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Tech Stocks Rebound, Tesla Soars To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
Via Benzinga
6 Analysts Have This To Say About Raymond James Finl
Via Benzinga
A Peek at Raymond James Finl's Future Earnings
Via Benzinga
Assessing Raymond James Finl: Insights From 7 Financial Analysts
Via Benzinga
Tech Stocks Rebound With Tesla Soaring To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results. 
Via Benzinga
Raymond James Financial Reports Fiscal Fourth Quarter and Fiscal 2024 Results
From Raymond James Financial
Via GlobeNewswire
Wave Life Sciences Rockets 70% on Historic RNA Editing Success
Wave Life Sciences' RNA editing advances have generated investor interest as the company strives to become a leading force in the treatment of genetic diseases. 
Via MarketBeat
Looking Into Raymond James Finl's Recent Short Interest
Via Benzinga
Navigating 5 Analyst Ratings For Raymond James Finl
Via Benzinga
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest... 
Via Benzinga
Raymond James Analyst Turns Bullish, Investment Banking To Drive Revenue Growth (CORRECTED)
Raymond James Financial shares are trading higher Wednesday. Analysts from JMP Securities upgraded the stock from Market Perform to Market Outperform and announced a $146 price target. Here's a look at... 
Via Benzinga
This Home Depot Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
Via Benzinga
Peering Into Raymond James Finl's Recent Short Interest
Via Benzinga
Investortools Integrates SumRidge Partners’ Liquidity into the Investortools Dealer Network, Expanding Secondary Market Visibility
From Investortools, Inc.
Via Business Wire
Community Gathers for Access to Healthcare Town Hall
Carver Financial Services helps smart investors with $500,000 ore more in assets achieve their vision. 
Via GlobePRwire
Raymond James Caravans’ Launches Its September Jamboree, Offering Attendees Substantial Discounts On Select Caravans
Via Press Release Distribution Service
What's Going On With Micron Stock?
Micron Technology shares are trading lower Thursday after Raymond James lowered its price target on the stock from $160 to $125. Here's what to know: 
Via Benzinga
Analyst Scoreboard: 4 Ratings For Raymond James Finl
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $11,000 Today
Via Benzinga
Applications Open October 1st for Raymond James Gasparilla Festival of the Arts (GFA) Emerging Artists Program
TAMPA, Fla. - Oct. 1, 2024 - PRLog -- The Raymond James Gasparilla Festival of the Arts (GFA) is excited to announce that the Emerging Artists Program (EAP) applications open on October 1st. This... 
Via PRLog
Raymond James Financial Declares Quarterly Dividends on Common and Preferred Stock
From Raymond James Financial
Via GlobeNewswire
Here's How Much You Would Have Made Owning Raymond James Finl Stock In The Last 5 Years
Via Benzinga
Why Nkarta Stock Is Soaring Today
One analyst is now more bullish about this clinical-stage biotech stock. 
Via The Motley Fool
Raymond James Just Issued a Major Warning on Nvidia (NVDA) Stock
All eyes remain on Nvidia, one of the most important stocks in the market. But here's why uncertainty around NVDA stock is growing. 
Via InvestorPlace
RJF Stock Earnings: Raymond James Finl Beats EPS, Misses Revenue for Q3 2024
RJF stock results show that Raymond James Finl beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024. 
Via InvestorPlace
Raymond James Financial Reports Fiscal Third Quarter of 2024 Results
From Raymond James Financial
Via GlobeNewswire
Bank Earnings Preview: Analyst Reveals 3 Favorites, But Downgrades JPMorgan And 2 Others
Wall Street gears up for Q2 earnings season, with focus on JPM, C, and WFC. Wolfe Research releases analysis and top picks: BAC, SCHW, LPLA. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.